Lung Function Improvements Tied to Better Asthma Control in Children

Source link :

In the VOYAGE trial, dupilumab (Dupixent) significantly reduced asthma exacerbations and improved lung function and asthma control in children (ages 6 to 11 years) with uncontrolled, moderate-to-severe asthma, with an acceptable safety profile. A post hoc analysis presented at the recent American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting, evaluated the association between […]

Author : News Health

Publish date : 2024-04-03 10:40:58

Copyright for syndicated content belongs to the linked Source.